ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Melinta Therapeutics Inc

Melinta Therapeutics Inc (MLNT)

0.50
0.00
( 0.00% )
更新日時: 09:00:00

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
0.50
買値
0.51
売値
0.5198
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
0.50
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

MLNT 最新ニュース

Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of Tetraphase

MORRISTOWN, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage antibiotics company, announced that on June 24, 2020, pursuant to the Agreement and...

Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals

Company Enters Growth Phase in Hospital Market with Support of Deerfield Acquisition to Augment Company’s Core Antibiotic Portfolio  MORRISTOWN, N. J. , June 09, 2020 (GLOBE NEWSWIRE) -- Melinta...

Melinta Therapeutics Confirms Deerfield as Successful Bidder for Company

MORRISTOWN, N.J., March 04, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (the “Company” or “Melinta”), a commercial-stage company focused on the development and commercialization of novel...

Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures

Bids due on March 2, 2020 by 4:00 p.m. Eastern Time Company Previously Announced Agreement of its Secured Lenders to Acquire Company as Going Concern, Subject to Higher and Better Offers Company...

Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility

MORRISTOWN, N.J., Dec. 27, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT) (the “Company” or “Melinta”), a commercial-stage company focused on the development and...

Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019

MORRISTOWN, N.J., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to...

Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...

~ Approval Based on Positive Phase III Trial Results of BAXDELA for Treatment of CABP in Adults~ ~ Company Delays Launch of CABP Indication Until Further Visibility Into Liquidity Position ~...

Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019

Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019 52 Presentations by Coalition Members During the Annual Meeting PR Newswire WASHINGTON, Oct. 1, 2019...

Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director

MORRISTOWN, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (Nasdaq: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics...

Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan

MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
CNEYCN Energy Group Inc
US$ 1.0009
(72.60%)
185.79M
ONCOOnconetix Inc
US$ 5.1601
(53.78%)
30.09M
TCTMTCTM Kids IT Education Inc
US$ 1.29
(35.79%)
6.18M
XPONExpion360 Inc
US$ 0.0873
(35.56%)
183.46M
FAASDigiAsia Corporation
US$ 2.6917
(28.79%)
2.51M
ICGIntchains Group Ltd
US$ 5.0201
(-40.80%)
1.65M
EDBLEdible Garden AG Inc
US$ 0.2757
(-40.74%)
3.28M
NVNOenVVeno Medical Corporation
US$ 3.41
(-24.22%)
1.37M
IVPInspire Veterinary Partners Inc
US$ 0.47
(-21.54%)
2.38M
SEELSeelos Therapeutics Inc
US$ 3.9501
(-21.00%)
1M
CNEYCN Energy Group Inc
US$ 1.0009
(72.60%)
185.79M
XPONExpion360 Inc
US$ 0.0873
(35.56%)
183.46M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.15725
(15.12%)
177.39M
NVDANVIDIA Corporation
US$ 120.64
(-2.74%)
131.62M
DUOFangDD Network Group Ltd
US$ 1.215
(13.55%)
67.1M